ppreston

My oncology office routinely brings chemotherapy patients back to the office to provide something they will call patient teaching (where the nurse or PA will talk about the risks of chemotherapy, side effects, etc.) Does anyone have any reliable guidelines on this? I maintain that this is not separately billable & is considered a necessary part of the initial consultation or new patient visit(even if it is done on a different DOS) When I cautioned against this, our compliance officer "repackaged" the same visit into
something she named a risk assessment visit. The levels that are being chosen are 99214s or 99215s. I need to know where to look to find some proof that this is legal.
PPreston